-
Something wrong with this record ?
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC
A. Nast, P. Gisondi, AD. Ormerod, P. Saiag, C. Smith, PI. Spuls, P. Arenberger, H. Bachelez, J. Barker, E. Dauden, EM. de Jong, E. Feist, A. Jacobs, R. Jobling, L. Kemény, M. Maccarone, U. Mrowietz, KA. Papp, C. Paul, K. Reich, S. Rosumeck, T....
Language English Country England, Great Britain
Document type Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
PubMed
26481193
DOI
10.1111/jdv.13354
Knihovny.cz E-resources
- MeSH
- Acitretin therapeutic use MeSH
- Adalimumab therapeutic use MeSH
- Anti-Inflammatory Agents, Non-Steroidal therapeutic use MeSH
- Cyclosporine therapeutic use MeSH
- Etanercept therapeutic use MeSH
- Fumarates therapeutic use MeSH
- Immunosuppressive Agents therapeutic use MeSH
- Keratolytic Agents therapeutic use MeSH
- Drug Therapy, Combination MeSH
- Humans MeSH
- Methotrexate therapeutic use MeSH
- Psoriasis drug therapy MeSH
- Ustekinumab therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
3rd Faculty of Medicine Department of Dermatology Charles University Prague Czech Republic
Clinical Lead for Dermatology St Johns Institute of Dermatology St Thomas' Hospital London UK
Department of Dermatology Aberdeen Royal Infirmary Aberdeen UK
Department of Dermatology Academic Medical Center Amsterdam The Netherlands
Department of Dermatology Erasmus University Rotterdam The Netherlands
Department of Dermatology Hôpital Saint Louis Paris France
Department of Dermatology Inselspital Universitätsklinik für Dermatologie Bern Switzerland
Department of Dermatology Paul Sabatier University Toulouse France
Department of Dermatology Psoriasis Center University Medical Center Schleswig Holstein Kiel Germany
Department of Dermatology University Hospital Nijmegen Nijmegen The Netherlands
Dermatologikum Hamburg Hamburg Germany
Hospital Universitario de la Princesa Madrid Spain
Section of Dermatology and Venereology Department of Medicine University of Verona Verona Italy
Service de Dermatologie Hôpital Ambroise Paré Université Paris 5 Boulogne France
St Johns Institute of Dermatology St Thomas' Hospital London UK
SZTE Borgyogyaszati Klinika Szeged Hungary
University Medical Center Nijmegen St Radboud Nijmegen The Netherlands
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000946
- 003
- CZ-PrNML
- 005
- 20171216102738.0
- 007
- ta
- 008
- 170103s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jdv.13354 $2 doi
- 024 7_
- $a 10.1111/jdv.13354 $2 doi
- 035 __
- $a (PubMed)26481193
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Nast, A $u Division of Evidence Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 245 10
- $a European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC / $c A. Nast, P. Gisondi, AD. Ormerod, P. Saiag, C. Smith, PI. Spuls, P. Arenberger, H. Bachelez, J. Barker, E. Dauden, EM. de Jong, E. Feist, A. Jacobs, R. Jobling, L. Kemény, M. Maccarone, U. Mrowietz, KA. Papp, C. Paul, K. Reich, S. Rosumeck, T. Talme, HB. Thio, P. van de Kerkhof, RN. Werner, N. Yawalkar,
- 650 _2
- $a acitretin $x terapeutické užití $7 D017255
- 650 _2
- $a adalimumab $x terapeutické užití $7 D000068879
- 650 _2
- $a antiflogistika nesteroidní $x terapeutické užití $7 D000894
- 650 _2
- $a cyklosporin $x terapeutické užití $7 D016572
- 650 _2
- $a kombinovaná farmakoterapie $7 D004359
- 650 _2
- $a etanercept $x terapeutické užití $7 D000068800
- 650 _2
- $a fumaráty $x terapeutické užití $7 D005650
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresiva $x terapeutické užití $7 D007166
- 650 _2
- $a keratolytika $x terapeutické užití $7 D007641
- 650 _2
- $a methotrexát $x terapeutické užití $7 D008727
- 650 _2
- $a psoriáza $x farmakoterapie $7 D011565
- 650 _2
- $a ustekinumab $x terapeutické užití $7 D000069549
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gisondi, P $u Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
- 700 1_
- $a Ormerod, A D $u Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK.
- 700 1_
- $a Saiag, P $u Service de Dermatologie, Hôpital Ambroise Paré Université Paris V, Boulogne, France.
- 700 1_
- $a Smith, C $u Clinical Lead for Dermatology, St Johns Institute of Dermatology, St Thomas' Hospital, London, UK.
- 700 1_
- $a Spuls, P I $u Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
- 700 1_
- $a Arenberger, Petr $u Third Faculty of Medicine, Department of Dermatology, Charles University, Prague, Czech Republic. $7 nlk19990072992 $4
- 700 1_
- $a Bachelez, H $u Department of Dermatology, Hôpital Saint-Louis, Paris, France.
- 700 1_
- $a Barker, J $u St. Johns Institute of Dermatology, St. Thomas' Hospital, London, UK.
- 700 1_
- $a Dauden, E $u Hospital Universitario de la Princesa, Madrid, Spain.
- 700 1_
- $a de Jong, E M $u University Medical Center Nijmegen St Radboud, Nijmegen, The Netherlands.
- 700 1_
- $a Feist, E $u Medizinische Klinik mit Schwerpunkt Rheumatologie u. klinische Immonologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Jacobs, A $u Division of Evidence Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Jobling, R $u Cambridge, UK.
- 700 1_
- $a Kemény, L $u SZTE Borgyogyaszati Klinika, Szeged, Hungary.
- 700 1_
- $a Maccarone, M $u Roma, Italy.
- 700 1_
- $a Mrowietz, U $u Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany.
- 700 1_
- $a Papp, K A $u Waterloo, Canada.
- 700 1_
- $a Paul, C $u Department of Dermatology, Paul Sabatier University, Toulouse, France.
- 700 1_
- $a Reich, K $u Dermatologikum Hamburg, Hamburg, Germany.
- 700 1_
- $a Rosumeck, S $u Division of Evidence Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Talme, T $u Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
- 700 1_
- $a Thio, H B $u Department of Dermatology, Erasmus University, Rotterdam, The Netherlands.
- 700 1_
- $a van de Kerkhof, P $u Department of Dermatology, University Hospital Nijmegen, Nijmegen, The Netherlands.
- 700 1_
- $a Werner, R N $u Division of Evidence Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Yawalkar, N $u Department of Dermatology, Inselspital, Universitätsklinik für Dermatologie, Bern, Switzerland.
- 773 0_
- $w MED00002983 $t Journal of the European Academy of Dermatology and Venereology JEADV $x 1468-3083 $g Roč. 29, č. 12 (2015), s. 2277-94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26481193 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170112115741 $b ABA008
- 999 __
- $a ok $b bmc $g 1180086 $s 961513
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 29 $c 12 $d 2277-94 $e 20151019 $i 1468-3083 $m Journal of the European Academy of Dermatology and Venereology $n J Eur Acad Dermatol Venerol $x MED00002983
- LZP __
- $a Pubmed-20170103